Macrophage differentiation and polarization on a decellularized pericardial biomaterial

Biomaterials

Volumn 32, Issue 2, 2011, Pages 439-449

  Ariganello, Marianne B ^a   Simionescu, Dan T ^b   Labow, Rosalind S ^a,c   Michael Lee, J ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b AMRL   (United States)

^c UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

Acid phosphatase; Biocompatibility; Collagen; Cytokine; Macrophage; Matrix metalloproteinase

Indexed keywords

ACID PHOSPHATASE; ACID PHOSPHATASE ACTIVITIES; BIOMATERIAL IMPLANTATION; BOVINE PERICARDIUM; CYTOKINES; DECELLULARIZED; DIRECT DIFFERENTIATION; HUMAN MONOCYTES; MACROPHAGE CULTURE; MATRIX METALLOPROTEINASES; MONOCYTE-DERIVED MACROPHAGES; NATIVE COLLAGEN; POLYDIMETHYLSILOXANE PDMS; STUDY DESIGN; WOUND HEALING PROCESS;

ACIDS; BIOCOMPATIBILITY; BODY FLUIDS; COLLAGEN; PHOSPHATASES; POLYSTYRENES; SILICONES; TISSUE ENGINEERING;

MACROPHAGES;

ACID PHOSPHATASE; BIOMATERIAL; CD163 ANTIGEN; CD68 ANTIGEN; CD86 ANTIGEN; CYCLOPHILIN A; DECELLULARIZED BOVINE PERICARDIUM; DIMETICONE; GELATINASE A; GELATINASE B; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; INTERSTITIAL COLLAGENASE; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYSTYRENE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ARTICLE; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL INTERACTION; CELL MEMBRANE DEPOLARIZATION; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOBLOTTING; MACROPHAGE; MONOCYTE; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

ACID PHOSPHATASE; ANIMALS; BIOCOMPATIBLE MATERIALS; CATTLE; CELL DIFFERENTIATION; CELL POLARITY; CELLS, CULTURED; CYTOKINES; GELATINASES; HUMANS; IMMUNOBLOTTING; INTERLEUKIN-10; INTERLEUKIN-8; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, SCANNING; PERICARDIUM; POLYMERASE CHAIN REACTION;

BOVINAE;

EID: 78449254303     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.09.004     Document Type: Article

References (46)

1. Gilbert T.W., Sellaro T.L., Badylak S.F. Decellularization of tissues and organs. Biomaterials 2006, 27(19):3675-3683.
2. Schmidt C.E., Baier J.M. Acellular vascular tissues: natural biomaterials for tissue repair and tissue engineering. Biomaterials 2000, 21(22):2215-2231.
3. Badylak S.F., Freytes D.O., Gilbert T.W. Extracellular matrix as a biological scaffold material: structure and function. Acta Biomater 2009, 5(1):1-13.
4. Simon P., Kasimir M.T., Seebacher G., Weigel G., Ullrich R., Salzer-Muhar U., et al. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003, 23(6):1002-1006. [discussion 1006].
5. Fujiwara N., Kobayashi K. Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 2005, 4(3):281-286.
6. Anderson J.M., Rodriguez A., Chang D. Foreign body reaction to biomaterials. Semin Immunol 2008, 20(2):86-100.
7. Badylak S.F., Valentin J.E., Ravindra A.K., McCabe G.P., Stewart-Akers A.M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 2008, 14(11):1835-1842.
8. Mantovani A., Sica A., Locati M. New vistas on macrophage differentiation and activation. Eur J Immunol 2007, 37(1):14-16.
9. Rieder E., Seebacher G., Kasimir M.T., Eichmair E., Winter B., Dekan B., et al. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 2005, 111(21):2792-2797.
10. Kasimir M.T., Rieder E., Seebacher G., Nigisch A., Dekan B., Wolner E., et al. Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis 2006, 15(2):278-286. [discussion 286].
11. Ariganello M.B., Labow R., Lee J.M. Response of macrophage-like U937 cells to decellularized tissue heart valve materials. J Heart Valve Dis 2009, 18(2):187-197.
12. Ariganello M., Labow R.S., Lee J.M. In vitro response of monocyte-derived macrophages to a decellularized pericardial biomaterial. J Biomed Mater Res A 2010, 93(1):280-288.
13. Trowbridge E.A. Mechanical characteristics of pericardial tissue and their relevance to bioprosthetic design. Crit Rev Biocompat 1989, 5:105-172.
14. Belanger M.C., Marois Y. Hemocompatibility, biocompatibility, inflammatory and in vivo studies of primary reference materials low-density polyethylene and polydimethylsiloxane: a review. J Biomed Mater Res 2001, 58(5):467-477.
15. Labow R.S., Meek E., Santerre J.P. Differential synthesis of cholesterol esterase by monocyte-derived macrophages cultured on poly(ether or ester)-based poly(urethane)s. J Biomed Mater Res 1998, 39(3):469-477.
16. Labow R.S., Meek E., Santerre J.P. Model systems to assess the destructive potential of human neutrophils and monocyte-derived macrophages during the acute and chronic phases of inflammation. J Biomed Mater Res 2001, 54(2):189-197.
17. Dinnes D.L., Santerre J.P., Labow R. Influence of biodegradable and non-biodegradable material surfaces on the differentiation of human monocyte-derived macrophages. Differentiation 2008, 76(3):232-244.
18. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408.
19. Matheson L., Maksym G., Santerre J.P., Labow R. The functional response of U937 macrophage-like cells is modulated by extracellular matrix proteins and mechanical strain. Biochem Cell Biol 2006, 84(5):763-773.
20. Schutte R.J., Parisi-Amon A., Reichert W.M. Cytokine profiling using monocytes/macrophages cultured on common biomaterials with a range of surface chemistries. J Biomed Mater Res A 2009, 88(1):128-139.
21. McBane J.E., Santerre J.P., Labow R. Effect of phorbol esters on the macrophage-mediated biodegradation of polyurethanes via protein kinase C activation and other pathways. J Biomater Sci Polym Ed 2009, 20(4):437-453.
22. Anderson J.M., Defife K., McNally A., Collier T., Jenney C. Monocyte, macrophage and foreign body giant cell interactions with molecularly engineered surfaces. J Mater Sci Mater Med 1999, 10(10/11):579-588.
23. Anderson J.M. Multinucleated giant cells. Curr Opin Hematol 2000, 7(1):40-47.
24. Martinez-Pomares L., Platt N., McKnight A.J., da Silva R.P., Gordon S. Macrophage membrane molecules: markers of tissue differentiation and heterogeneity. Immunobiology 1996, 195(4-5):407-416.
25. Heino J. The collagen receptor integrins have distinct ligand recognition and signaling functions. Matrix Biol 2000, 19(4):319-323.
26. Gasque P. Complement: a unique innate immune sensor for danger signals. Mol Immunol 2004, 41(11):1089-1098.
27. Andersson J., Ekdahl K.N., Lambris J.D., Nilsson B. Binding of C3 fragments on top of adsorbed plasma proteins during complement activation on a model biomaterial surface. Biomaterials 2005, 26(13):1477-1485.
28. Visse R., Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003, 92(8):827-839.
29. Speidl W.S., Toller W.G., Kaun C., Weiss T.W., Pfaffenberger S., Kastl S.P., et al. Catecholamines potentiate LPS-induced expression of MMP-1 and MMP-9 in human monocytes and in the human monocytic cell line U937: possible implications for peri-operative plaque instability. FASEB J 2004, 18(3):603-605.
30. Williams T.N., Zhang C.X., Game B.A., He L., Huang Y. C-reactive protein stimulates MMP-1 expression in U937 histiocytes through Fc [gamma]RII and extracellular signal-regulated kinase pathway:: an implication of CRP involvement in plaque destabilization. Arterioscler Thromb Vasc Biol 2004, 24(1):61-66.
31. Van Lint P., Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 2007, 82(6):1375-1381.
32. McQuibban G.A., Gong J.H., Wong J.P., Wallace J.L., Clark-Lewis I., Overall C.M. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002, 100(4):1160-1167.
33. Parks W.C., Wilson C.L., López-Boado Y.S. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004, 4(8):617-629.
34. Lolmede K., Campana L., Vezzoli M., Bosurgi L., Tonlorenzi R., Clementi E., et al. Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways. J Leukoc Biol 2009, 85(5):779-787.
35. Drexler H.G., Klein M., Bhoopalam N., Menon M., Messmore H.L., Gaedicke G., et al. Expression of a monocyte-specific esterase isoenzyme in cases of acute myeloid leukemias. Eur J Cancer Clin Oncol 1985, 21(12):1485-1491.
36. Uphoff C.C., Drexler H.G. Biology of monocyte-specific esterase. Leuk Lymphoma 2000, 39(3-4):257-270.
37. Bune A.J., Hayman A.R., Evans M.J., Cox T.M. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus. Immunology 2001, 102(1):103-113.
38. Lasser A. The mononuclear phagocytic system: a review. Hum Pathol 1983, 14(2):108-126.
39. Donaldson K., Bolton R.E., Brown D., Douglas A. An improved macrophage spreading assay-a simple and effective measure of activation. Immunol Commun 1984, 13(3):229-244.
40. Nishise S., Takeda Y., Takeda H., Ishihama K., Fukui T., Kawata S. Complement activation is involved in biological responses to leukocyte adsorptive apheresis. Dig Dis Sci 2006, 51(5):934-941.
41. Rogers P.D., Stiles J.K., Chapman S.W., Cleary J.D. Amphotericin B induces expression of genes encoding chemokines and cell adhesion molecules in the human monocytic cell line THP-1. J Infect Dis 2000, 182(4):1280-1283.
42. Jones J., Chang D., Meyerson H., Colton E., Kwon I., Matsuda T., et al. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. J Biomed Mater Res A 2007, 83(3):585-596.
43. McNally A.K., Anderson J.M. Interleukin-4 induces foreign body giant cells from human monocytes/macrophages. Differential lymphokine regulation of macrophage fusion leads to morphological variants of multinucleated giant cells. Am J Pathol 1995, 147(5):1487-1499.
44. Baldwin L., Hunt J.A. The in vivo cytokine release profile following implantation. Cytokines 2008, 41(3):217-222.
45. Wang X., Lennartz M.R., Loegering D.J., Stenken J.A. Multiplexed cytokine detection of interstitial fluid collected from polymeric hollow tube implants-a feasibility study. Cytokines 2008, 43(1):15-19.
46. Allman A.J., McPherson T.B., Badylak S.F., Merrill L.C., Kallakury B., Sheehan C., et al. Xenogeneic extracellular matrix grafts elicit a TH2-restricted immune response. Transplantation 2001, 71(11):1631-1640.